Homoharringtonine targets XPC to inhibit DNA damage repair and sensitize tumors to platinum-based chemotherapy

Case Report: Apparent progressive complete mismatch repair protein loss during platinum-based chemotherapy in metastatic rectal neuroendocrine tumour grade 2
Yue Yang, Gao Li, Jinghui Wang +2
Frontiers in oncology16 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMC
Intensity-modulated radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer: a single-institutional phase II investigator-initiated nonrandomized clinical trial
Chi Fang, Suping Liu, Jie Xia +3
Journal of Cancer Research and Clinical Oncology28 Jul 2026Peer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsPMC
Hsp10 Targets the C-Terminus of α-Synuclein to Inhibit Secondary Nucleation and Remodel Labile Fibrils
M. A. Hegetschweiler, M. S. Oliyantakath Hassan, S. Call +2
bioRxiv23 Oct 2026PreprintCC BY-NDFull textNeurologybioRxiv
miR-615-3p targets SESN2 to inhibit neuronal mitophagy in an in vitro Alzheimer’s disease model by regulating the AMPK/ULK1 axis
Yang Jing, DeKun Li, Li Chen +2
Frontiers in molecular neuroscience16 Oct 2026Peer-reviewedCC BYFull textPhysiologyEurope PMCPMC
Third-generation EGFR-TKI plus pemetrexed-platinum chemotherapy versus TKI monotherapy as first-line treatment for EGFR-mutant lung adenocarcinoma with brain parenchymal metastases
Jianxi Zhou, Yinghao Wang, Kang Wen +4
Frontiers in Pharmacology7 Oct 2026Peer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefEurope PMC

Cite

BibTeX

@misc{wang2026homoharringtonine,
  title = {{Homoharringtonine targets XPC to inhibit DNA damage repair and sensitize tumors to platinum-based chemotherapy}},
  author = {C. Wang and Y. Zhang and X. Zhou and J. He and L. Liu and L. Wang and Y. Zhang and Q. Gong and J. Zhang and Y. Dang and J. Wu},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.27.762176},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.27.762176v1},
}

RIS

TY  - UNPB
TI  - Homoharringtonine targets XPC to inhibit DNA damage repair and sensitize tumors to platinum-based chemotherapy
AU  - C. Wang
AU  - Y. Zhang
AU  - X. Zhou
AU  - J. He
AU  - L. Liu
AU  - L. Wang
AU  - Y. Zhang
AU  - Q. Gong
AU  - J. Zhang
AU  - Y. Dang
AU  - J. Wu
PY  - 2026
DA  - 2026/10/27
PB  - bioRxiv
DO  - 10.64898/2026.10.27.762176
UR  - https://www.biorxiv.org/content/10.64898/2026.10.27.762176v1
ER  -

Related

Cite